Metastatic Colorectal Cancers Not Yet Recruiting Phase 2 Trials for Panitumumab (DB01269)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03940131Re-challenge Therapy With Chemotherapy & Panitumumab in Metastatic Colorectal Cancer Patients Treated With an Anti-EGFRTreatment